BRD2 and neoplasm: Apart from the fact that the CA 19-9 measurement may be useless in an important percentage of cases [24,97,98] and that its post-NAT decrease or normalization cannot be associated independently with survival [161], the CA 19-9 value may only be useful for estimating tumor burden and not tumor metabolic capacity or ability to metastasize.